You just read:

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

News provided by

Reportlinker

Apr 23, 2014, 01:21 ET